Access Bio (XKRX:950130) Ending Cash Position : ₩340,379 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Access Bio Ending Cash Position?

Access Bio's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩340,379 Mil.

Access Bio's quarterly Ending Cash Position declined from Sep. 2023 (₩314,259 Mil) to Dec. 2023 (₩277,607 Mil) but then increased from Dec. 2023 (₩277,607 Mil) to Mar. 2024 (₩340,379 Mil).

Access Bio's annual Ending Cash Position increased from Dec. 2021 (₩199,083 Mil) to Dec. 2022 (₩473,199 Mil) but then declined from Dec. 2022 (₩473,199 Mil) to Dec. 2023 (₩277,607 Mil).

Access Bio Ending Cash Position Historical Data

The historical data trend for Access Bio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Ending Cash Position Chart

Access Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

6,835.71

49,210.76

199,082.95

473,199.04

277,606.82

Access Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															514,749.78	452,479.25	314,258.76	277,606.82	340,379.22

Access Bio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Access Bio's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	481450.99	+	-203844.171
	=	277,607

Access Bio's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	289964.994	+	50414.228
	=	340,379

Access Bio Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Access Bio's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Access Bio (XKRX:950130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Clyde Road, Suite A, Somerset, NJ, USA, 08873

Website

http://www.accessbio.net

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio (XKRX:950130) Headlines

No Headlines